116 related articles for article (PubMed ID: 22245236)
21. Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai.
Kimkong I; Chankaew J; Kunanopparat A; Hirankarn N; Tangkijvanich P
Tissue Antigens; 2015 Mar; 85(3):177-81. PubMed ID: 25664396
[TBL] [Abstract][Full Text] [Related]
22. Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis.
Akuta N; Suzuki F; Seko Y; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Hara T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
Hepatology; 2012 Dec; 56(6):2134-41. PubMed ID: 22806754
[TBL] [Abstract][Full Text] [Related]
23. Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma.
Ren S; Lu J; Du X; Huang Y; Ma L; Huo H; Chen X; Wei L
Cancer Immunol Immunother; 2012 Sep; 61(9):1433-9. PubMed ID: 22310928
[TBL] [Abstract][Full Text] [Related]
24. Association of interleukin-28B genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis C.
Hodo Y; Honda M; Tanaka A; Nomura Y; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Sakai A; Sasaki M; Nakanuma Y; Moriyama M; Kaneko S
Clin Cancer Res; 2013 Apr; 19(7):1827-37. PubMed ID: 23426277
[TBL] [Abstract][Full Text] [Related]
25. IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.
Echeverría N; Chiodi D; López P; Sanchez Ciceron A; Angulo J; López-Lastra M; Silvera P; Canavesi A; Bianchi C; Colistro V; Cristina J; Hernandez N; Moreno P
Virol J; 2018 Mar; 15(1):40. PubMed ID: 29499724
[TBL] [Abstract][Full Text] [Related]
26. CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection.
Itakura J; Nagayama K; Enomoto N; Sakamoto N; Tazawa J; Izumi N; Marumo F; Sato C
J Med Virol; 2001 Jan; 63(1):22-8. PubMed ID: 11130883
[TBL] [Abstract][Full Text] [Related]
27. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
[TBL] [Abstract][Full Text] [Related]
28. Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients.
Ibrahim MK; Salama H; Abd El Rahman M; Dawood RM; Bader El Din NG; Salem HF; Abdelrahim ME; Omran D; Omran MH; El-Wakeel KH; Abdelhafez TH; Khedr A; El Awady MK
J Interferon Cytokine Res; 2016 Dec; 36(12):698-705. PubMed ID: 27726464
[TBL] [Abstract][Full Text] [Related]
29. Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection.
Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Alkahtani S; Alarifi S; Alkahtane AA; Al-Yahya H; Ali D; Alessia MS; Alshahrani B; Al-Ahdal MN; Al-Qahtani AA
J Immunol Res; 2017; 2017():1590653. PubMed ID: 28127569
[TBL] [Abstract][Full Text] [Related]
30. Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection.
Marabita F; Aghemo A; De Nicola S; Rumi MG; Cheroni C; Scavelli R; Crimi M; Soffredini R; Abrignani S; De Francesco R; Colombo M
Hepatology; 2011 Oct; 54(4):1127-34. PubMed ID: 21721028
[TBL] [Abstract][Full Text] [Related]
31. Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection.
De Re V; Gragnani L; Fognani E; Piluso A; Izzo F; Mangia A; Crovatto M; Gava G; Casarin P; Sansonno D; Racanelli V; De Vita S; Pioltelli P; Caggiari L; De Zorzi M; Berretta M; Gini A; Zucchetto A; Buonaguro FM; De Paoli P; Zignego AL
Biomed Res Int; 2014; 2014():710642. PubMed ID: 24707497
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence.
Lee DH; Cho Y; Seo JY; Kwon JH; Cho EJ; Jang ES; Kwak MS; Cheong JY; Cho SW; Lee JH; Yu SJ; Yoon JH; Lee HS; Kim CY; Shin HD; Kim YJ
Intervirology; 2013; 56(2):84-90. PubMed ID: 23343781
[TBL] [Abstract][Full Text] [Related]
33. MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C.
Dharel N; Kato N; Muroyama R; Moriyama M; Shao RX; Kawabe T; Omata M
Clin Cancer Res; 2006 Aug; 12(16):4867-71. PubMed ID: 16914573
[TBL] [Abstract][Full Text] [Related]
34. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
Zhang QX; Li SL; Yao YQ; Li TJ
Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
[TBL] [Abstract][Full Text] [Related]
35. IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.
Rao HY; Sun DG; Jiang D; Yang RF; Guo F; Wang JH; Liu F; Zhang HY; Zhang HH; Du SC; Jin Q; Qin H; Lok AS; Wei L
J Viral Hepat; 2012 Mar; 19(3):173-81. PubMed ID: 22329371
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.
Kumar V; Kato N; Urabe Y; Takahashi A; Muroyama R; Hosono N; Otsuka M; Tateishi R; Omata M; Nakagawa H; Koike K; Kamatani N; Kubo M; Nakamura Y; Matsuda K
Nat Genet; 2011 May; 43(5):455-8. PubMed ID: 21499248
[TBL] [Abstract][Full Text] [Related]
37. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
[TBL] [Abstract][Full Text] [Related]
38. IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection.
Moghaddam A; Melum E; Reinton N; Ring-Larsen H; Verbaan H; Bjøro K; Dalgard O
Hepatology; 2011 Mar; 53(3):746-54. PubMed ID: 21374656
[TBL] [Abstract][Full Text] [Related]
39. IL28B polymorphisms of both recipient and donor cooperate to influence IFN treatment response in HCV recurrence after liver transplantation, but IL28B SNPs of the recipient play a major role in IFN-induced blocking of HCV replication.
Barbera F; Russelli G; Pipitone L; Pietrosi G; Corsale S; Vizzini G; Gridelli B; Conaldi PG
New Microbiol; 2015 Apr; 38(2):201-10. PubMed ID: 25938745
[TBL] [Abstract][Full Text] [Related]
40. The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.
Derbala M; Rizk NM; Al-Kaabi S; John A; Sharma M; El-dweik N; Yakoob R; Pasic F; Almohanadi M; Alejji K; Abdelmola A; Butt M
Virology; 2013 Sep; 444(1-2):292-300. PubMed ID: 23866096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
